iSOFT Signs Sixth LORENZO Site in Germany

iSOFT Group LimitediSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced that Christophorus-Kliniken will become the sixth early adopter of iSOFT’s LORENZO next-generation solution in Germany as part of an agreement to upgrade hospital information systems (HIS) at its three hospitals in the Coesfeld district of North Rhine-Westphalia.

The five-year deal potentially is worth as much as €1.43 million (A$2.5 million). The initial two phases, which include the first LORENZO components and an upgrade of iSOFT's ClinicCentre HIS solution, are valued at €675,000 (A$1.2 million) in license fees and services plus €257,000 (A$447,000) in support and maintenance services over five years. An optional third phase, which includes additional LORENZO functionality, is worth a potential €500,000 (A$870,000).

"This is further evidence that our new LORENZO technology is gaining traction with our existing client base in Europe," said Gary Cohen, iSOFT's Executive Chairman & CEO. "It's part of our broader strategy for LORENZO outside of the UK's National Programme for Information Technology."

The first LORENZO elements and iSOFT's Collaboration Suite (iCS) will provide a new electronic patient record (EPR) for GP's to access hospital patient records using standard web browsers. iCS allows the secure exchange of patient information between care providers to improve collaboration between teams.

Christophorus-Kliniken follows Klinikum Saarbrücken, which recently became iSOFT's fifth LORENZO early adopter in Germany. The three Christophorus-Kliniken hospitals covered by the new contract are Coesfeld's St Vincenz Hospital, Franz Hospital at Dülmen and St Gerburgis Hospital at Nottuln, which provide a total of 620 beds and employ 1,500 staff.

Christophorus-Kliniken is an existing client for iSOFT's ClinicCentre and its LabCentre laboratory information system and BusinessCentre finance, administration and management solution.

Other LORENZO early adopters in Germany are Aachen, Leipzig, Krankenhaus Buchholz and Winsen, and Klinikum Saarbrücken.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 38 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 16 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...